Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury

Stéphanie Bieber1,2, Angelina Kraechan3,4, Johannes C Hellmuth4,5

  • 1Medizinische Klinik und Poliklinik I, Klinikum der Universitaet Muenchen, Ludwig-Maximilians-University, Marchioninistraße 15, 81377, Munich, Germany. Stephanie.Bieber@med.uni-muenchen.de.

Infection
|January 30, 2021
PubMed

Insights

COVID-19 can cause heart muscle injury, leading to ventricular dysfunction. Echocardiography revealed impaired left and right ventricular function in patients with myocardial injury, which showed partial recovery over time.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Imaging

Background:

  • COVID-19, caused by SARS-COV-2, is a multi-organ disease.
  • Myocardial injury is a known complication, but its echocardiographic characteristics are not fully understood.

Purpose of the Study:

  • To characterize echocardiographic patterns of ventricular function in patients with COVID-19-associated myocardial injury.

Main Methods:

  • Prospective assessment of 32 hospitalized COVID-19 patients using comprehensive 3D and strain echocardiography.
  • Patients were categorized based on elevated high-sensitivity troponin T (hsTNT+ vs. hsTNT-).

Main Results:

  • 65.7% of patients exhibited left and/or right ventricular dysfunction.
  • hsTNT+ patients commonly showed biventricular dysfunction, impaired left ventricular global longitudinal strain (GLS), and reduced right ventricular (RV) systolic function.
  • Myocardial dysfunction partially recovered in hsTNT+ patients after 52 days.

Conclusions:

  • COVID-19-associated myocardial injury is linked to left and right ventricular dysfunction.
  • Echocardiography, particularly 3D and strain imaging, effectively revealed these dysfunctions.
  • Ventricular dysfunction showed partial resolution at a 2-month follow-up.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
72
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
162
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
151
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
148
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
173
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
197